The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer.

Devlin, Lynsey; Grocutt, Laura; Hunter, Bianca; Chemu, Hiwot; Duffton, Aileen; McDonald, Alec; Macleod, Nicholas; McLoone, Philip; O'Cathail, Sean M

Devlin, Lynsey; Grocutt, Laura; Hunter, Bianca; Chemu, Hiwot; Duffton, Aileen; McDonald, Alec; Macleod, Nicholas; McLoone, Philip; O'Cathail, Sean M.

Afiliação

Devlin L; Department of Radiotherapy, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Grocutt L; CRUK RadNet Glasgow, University of Glasgow, Glasgow, United Kingdom.
Hunter B; CRUK RadNet Glasgow, University of Glasgow, Glasgow, United Kingdom.
Chemu H; Department of Radiotherapy Physics, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Duffton A; Department of Radiotherapy Physics, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
McDonald A; Department of Clinical Oncology, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Macleod N; Department of Radiotherapy, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
McLoone P; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
O'Cathail SM; Department of Clinical Oncology, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.

Clin Transl Radiat Oncol ; 36: 24-30, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35756193

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google